Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Jazz Pharmaceuticals plc shares valued at $206,821 were sold by Carr Patricia on Mar 07 ’24. At $116.98 per share, Carr Patricia sold 1,768 shares. The insider’s holdings dropped to 6,596 shares worth approximately $0.82 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Carr Patricia sold 1,936 shares, netting a total of over 231,628 in proceeds. Following the sale of shares at $119.64 each, the insider now holds 8,364 shares.
Before that, Johnson Philip L had added 12,000 shares to its account. In a trade valued at $1,435,800, the EVP & Chief Financial Officer bought Jazz Pharmaceuticals plc shares for $119.65 each. Upon closing the transaction, the insider’s holdings increased to 12,000 shares, worth approximately $3.49 million.
As published in their initiating research note from Robert W. Baird on January 03, 2024, Jazz Pharmaceuticals plc [JAZZ] has been an Outperform and the price target has been revised to $160. Analysts at UBS downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late November. As of September 29, 2023, Raymond James has initiated its “Mkt perform” rating for JAZZ.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 5.96%. Over the course of the year, Jazz Pharmaceuticals plc shares have jumped approximately 1.46%. Shares of the company reached a 52-week high of $134.17 on 02/26/24 and a 52-week low of $113.55 on 01/19/24. A 50-day SMA is recorded $122.33, while a 200-day SMA reached $127.04. Nevertheless, trading volume fell to 0.68 million shares from 0.8 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 123.58, which, if violated, would cause prices to drop to 122.38. In the upper region, resistance lies at 125.82. The next price resistance is at 126.86. RSI (Relative Strength Index) is 57.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 5.22, which suggests the price will increase in the coming days. Percent R is at 8.43%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Jazz Pharmaceuticals plc subject to short interest?
Stocks of Jazz Pharmaceuticals plc saw a sharp rise in short interest on Feb 29, 2024 jumping by 0.18 million shares to 2.39 million. Data from Yahoo Finance shows that the short interest on Jan 31, 2024 was 2.21 million shares. A jump of 7.53% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.4 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.4.
